• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Purdue Pharma

Biotech

Amyloidosis biotech Attralus nabs $116M for clinical development

Attralus Therapeutics has scored $116 million to bring a handful of amyloidosis therapies into the clinic.
Emmy Lucas Sep 8, 2021 3:28pm

Purdue subsidiary buys non-opioid pain prospect

Aug 11, 2021 8:20am

Ex-Purdue CEO Timney lands at amyloidosis biotech Attralus

May 11, 2021 11:05am

Former Merrimack CEO becomes new Yumanity chief—Chutes & Ladders

Jul 12, 2019 9:30am

Purdue hires Ducharme as CSO to aid expansion beyond opioids

Jul 3, 2019 10:35am

Eisai buys Purdue stake in insomnia drug as PDUFA date nears

May 1, 2019 9:28am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy